Mercator Medical S.A.
MRC.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | PLN 145 | PLN 143 | PLN 148 | PLN 144 |
| % Growth | 1.3% | -3% | 2.2% | – |
| Cost of Goods Sold | PLN 118 | PLN 109 | PLN 104 | PLN 103 |
| Gross Profit | PLN 27 | PLN 34 | PLN 44 | PLN 41 |
| % Margin | 18.4% | 24% | 29.5% | 28.5% |
| R&D Expenses | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| G&A Expenses | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| SG&A Expenses | PLN 0 | PLN 0 | PLN 29 | PLN 36 |
| Sales & Mktg Exp. | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Other Operating Expenses | PLN 41 | PLN 49 | PLN 16 | -PLN 18 |
| Operating Expenses | PLN 41 | PLN 49 | PLN 45 | PLN 18 |
| Operating Income | PLN 1 | -PLN 13 | -PLN 1 | PLN 23 |
| % Margin | 0.4% | -9.2% | -0.7% | 15.9% |
| Other Income/Exp. Net | PLN 5 | PLN 7 | PLN 22 | -PLN 10 |
| Pre-Tax Income | PLN 6 | -PLN 6 | PLN 21 | PLN 13 |
| Tax Expense | PLN 1 | PLN 3 | -PLN 10 | -PLN 8 |
| Net Income | PLN 5 | -PLN 9 | PLN 30 | PLN 21 |
| % Margin | 3.3% | -6.5% | 20.2% | 14.5% |
| EPS | 0.51 | -1.01 | 3.22 | 2.24 |
| % Growth | 150.5% | -131.4% | 43.7% | – |
| EPS Diluted | 0.51 | -1.01 | 3.22 | 2.24 |
| Weighted Avg Shares Out | 9 | 9 | 9 | 9 |
| Weighted Avg Shares Out Dil | 9 | 9 | 9 | 9 |
| Supplemental Information | – | – | – | – |
| Interest Income | PLN 4 | PLN 4 | PLN 4 | PLN 4 |
| Interest Expense | PLN 0 | PLN 1 | PLN 0 | PLN 0 |
| Depreciation & Amortization | PLN 8 | PLN 7 | PLN 6 | PLN 5 |
| EBITDA | PLN 13 | PLN 2 | PLN 27 | PLN 0 |
| % Margin | 9.1% | 1.1% | 18.3% | 0.1% |